So basically they've paintented an entire approach to the treatment of KD. Smart move. The must be confident that this protein is a key to treatment and have locked themselves into royalties if they or anybody else develops a treatment using this approach. Suddenly PromarkerD has become a when lot more valuable!
Ann: US patent for identifying drugs for abnormal kidney function, page-3
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
67.0¢ |
Change
-0.010(1.47%) |
Mkt cap ! $85.15M | |||
| Open | High | Low | Value | Volume |
| 69.0¢ | 70.0¢ | 67.0¢ | $57.49K | 84.97K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12624 | 67.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 70.0¢ | 24780 | 3 |
View Market Depth
| Last trade - 15.49pm 21/11/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |
